Literature DB >> 23017716

Glucocorticoid effects on adiponectin expression.

Siddharth Sukumaran1, Debra C Dubois, William J Jusko, Richard R Almon.   

Abstract

Maintenance of energy metabolism and glucose homeostasis is achieved by the regulatory effects of many hormones and their interactions. Glucocorticoids produced from adrenal cortex and adiponectin produced by adipose tissue play important roles in the production, distribution, storage, and utilization of energy substrates. Glucocorticoids are involved in the activation of a number of catabolic processes by affecting the expression of a plethora of genes, while adiponectin acts primarily as an insulin sensitizer. Both are regulated by a number of physiological and pharmacological factors. Although the effects of glucocorticoids on adiponectin expression have been extensively studied in different in vitro, animal and clinical study settings, no consensus has been reached. This report reviews the primary literature concerning the effects of glucocorticoids on adiponectin expression and identifies potential reasons for the contradictory results between different studies. In addition, methods to gain better insights pertaining to the regulation of adiponectin expression are discussed.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23017716      PMCID: PMC3693220          DOI: 10.1016/B978-0-12-398313-8.00007-5

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  75 in total

1.  Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.

Authors:  Nicholas M Morton; Janice M Paterson; Hiroaki Masuzaki; Megan C Holmes; Bart Staels; Catherine Fievet; Brian R Walker; Jeffrey S Flier; John J Mullins; Jonathan R Seckl
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

Review 2.  Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations.

Authors:  Adam J Rose; Alexandros Vegiopoulos; Stephan Herzig
Journal:  J Steroid Biochem Mol Biol       Date:  2010-02-17       Impact factor: 4.292

3.  Insulin and endothelin in the acute regulation of adiponectin in vivo in humans.

Authors:  Lori A Brame; Robert V Considine; Mikako Yamauchi; Alain D Baron; Kieren J Mather
Journal:  Obes Res       Date:  2005-03

4.  Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes.

Authors:  Mathias Fasshauer; Johannes Klein; Susanne Neumann; Markus Eszlinger; Ralf Paschke
Journal:  Biochem Biophys Res Commun       Date:  2002-01-25       Impact factor: 3.575

5.  A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens.

Authors:  Richard R Almon; Debra C DuBois; William J Jusko
Journal:  Endocrinology       Date:  2007-02-15       Impact factor: 4.736

6.  Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression.

Authors:  Siddharth Sukumaran; William J Jusko; Debra C DuBois; Richard R Almon
Journal:  J Pharmacol Exp Ther       Date:  2011-03-11       Impact factor: 4.030

Review 7.  Adiponectin in insulin resistance: lessons from translational research.

Authors:  Florencia Ziemke; Christos S Mantzoros
Journal:  Am J Clin Nutr       Date:  2009-11-11       Impact factor: 7.045

8.  Effects of short-term corticoid ingestion on food intake and adipokines in healthy recreationally trained men.

Authors:  N Rieth; L Jollin; B Le Panse; A-M Lecoq; A Arlettaz; J De Ceaurriz; K Collomp
Journal:  Eur J Appl Physiol       Date:  2008-11-05       Impact factor: 3.078

9.  Adiponectin and protection against type 2 diabetes mellitus.

Authors:  Joachim Spranger; Anja Kroke; Matthias Möhlig; Manuela M Bergmann; Michael Ristow; Heiner Boeing; Andreas F H Pfeiffer
Journal:  Lancet       Date:  2003-01-18       Impact factor: 79.321

10.  Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents.

Authors:  Bodil Bjørndal; Lena Burri; Vidar Staalesen; Jon Skorve; Rolf K Berge
Journal:  J Obes       Date:  2011-02-15
View more
  12 in total

1.  Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism.

Authors:  Vivaswath S Ayyar; Richard R Almon; Debra C DuBois; Siddharth Sukumaran; Jun Qu; William J Jusko
Journal:  J Proteomics       Date:  2017-03-14       Impact factor: 4.044

Review 2.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

3.  Intermittent prednisone treatment in mice promotes exercise tolerance in obesity through adiponectin.

Authors:  Mattia Quattrocelli; Michelle Wintzinger; Karen Miz; Manoj Panta; Ashok D Prabakaran; Grant D Barish; Navdeep S Chandel; Elizabeth M McNally
Journal:  J Exp Med       Date:  2022-04-01       Impact factor: 14.307

Review 4.  Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.

Authors:  Mi-Jeong Lee; Pornpoj Pramyothin; Kalypso Karastergiou; Susan K Fried
Journal:  Biochim Biophys Acta       Date:  2013-06-02

5.  Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort.

Authors:  Magali Meyer; Jérémie Sellam; Soraya Fellahi; Salma Kotti; Jean-Philippe Bastard; Olivier Meyer; Frédéric Lioté; Tabassome Simon; Jacqueline Capeau; Francis Berenbaum
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

Review 6.  Adipose tissue and adrenal glands: novel pathophysiological mechanisms and clinical applications.

Authors:  Atil Y Kargi; Gianluca Iacobellis
Journal:  Int J Endocrinol       Date:  2014-06-11       Impact factor: 3.257

7.  Increased circulating adiponectin is an independent disease activity marker in patients with rheumatoid arthritis: A cross-sectional study using the KURAMA database.

Authors:  Hiroto Minamino; Masao Katsushima; Tamami Yoshida; Motomu Hashimoto; Yoshihito Fujita; Mirei Shirakashi; Wataru Yamamoto; Kosaku Murakami; Koichi Murata; Kohei Nishitani; Masao Tanaka; Hiromu Ito; Nobuya Inagaki; Shuichi Matsuda
Journal:  PLoS One       Date:  2020-03-03       Impact factor: 3.240

Review 8.  Title: "Labels Matter: Is it stress or is it Trauma?"

Authors:  Gal Richter-Levin; Carmen Sandi
Journal:  Transl Psychiatry       Date:  2021-07-10       Impact factor: 6.222

Review 9.  Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease.

Authors:  Mervin Chávez-Castillo; Manuel Nava; Ángel Ortega; Milagros Rojas; Victoria Núñez; Juan Salazar; Valmore Bermúdez; Joselyn Rojas-Quintero
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

10.  Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome.

Authors:  Tetsuro Tamai; Kaori Kamijo; Yoshifusa Abe; Satoshi Hibino; Shunsuke Sakurai; Shuichiro Watanabe; Yoshitaka Watanabe; Satomi Nimura; Atsutoshi Shiratori; Takaaki Takayanagi; Tsuneki Watanabe; Yuya Nakano; Hirokazu Ikeda; Kazushige Dobashi; Yasuko Nakano; Katsumi Mizuno; Kazuo Itabashi
Journal:  Clin Exp Nephrol       Date:  2021-06-01       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.